CXCR3 ligands, such as CXCL9, CXCL10, and CXCL11, are mainly produced by monocytes, endothelial cells, and tumour cells [224,225] and are crucial for regulating anti-tumour immunity. This evidence concerns the gene CXCL11 and neoplasm.